C Partners Holding Gmb H Amgen Inc Transaction History

C Partners Holding Gmb H

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 07, 2019	SELL	$178.4 - $208.25 $109,002 - $127,240	-611 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$185.29 - $208.89 $117,103 - $132,018	-632 Reduced 50.84%	611 $127,000
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $7,638 - $8,579	46 Added 3.84%	1,243 $229,000
Q1 2018 May 15, 2018	SELL	$169.43 - $198.0 $50,829 - $59,400	-300 Reduced 20.04%	1,197 $204,000
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $252,678 - $282,319	1,497	1,497 $260,000

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of C Partners Holding Gmb H, based on Form 13F filings with the SEC.

Stay updated on C Partners Holding Gmb H with notifications on news.